Proteomics technologies in endometriosis

Expert Review of Proteomics

Volumn 5, Issue 5, 2008, Pages 705-714

  Ferrero, Simone ^a,b   Gillott, David John ^b,c   Remorgida, Valentino ^a   Ragni, Nicola ^a   Venturini, Pier Luigi ^d   Grudzinskas, Jurgis Gedis ^b,c  

^a UNIVERSITY OF GENOA   (Italy)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^c London Bridge Fertility Gynaecology and Genetics Centre ^*  (United Kingdom)

^d G GASLINI INSTITUTE   (Italy)

Author keywords

2D electrophoresis; Diagnosis; Endometriosis; Pathogenesis; Proteomics; Serum

Indexed keywords

ACTIN RELATED PROTEIN; ACTIN RELATED PROTEIN 3; ALPHA TROPOMYOSIN; ANNEXIN; AUTOANTIBODY; BETA ACTIN; BIOLOGICAL MARKER; BULLOUS PEMPHIGOID ANTIGEN 1; CA 125 ANTIGEN; CARRIER PROTEIN; CELL ADHESION MOLECULE; CYCLIN A1; CYTIDINE DEAMINASE; ENDO 1,3(4) BETA GLUCANASE; ENDO 1,4 BETA XYLANASE; GROWTH FACTOR; HEAT SHOCK PROTEIN 70; METALLOPROTEINASE; MICROTUBULE ASSOCIATED PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 6; NUCLEAR TRANSPORT FACTOR 2; PLACENTA PROTEIN 14; POLYADENYLIC ACID BINDING PROTEIN; PREGNANCY ASSOCIATED ALPHA2 GLYCOPROTEIN; STRATIFIN; SYNAPSIN I; THREONINE PROTEINASE; TRANSGELIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VIMENTIN;

APOPTOSIS; COLON DILATATION; COMPUTER ASSISTED TOMOGRAPHY; CYTOKINE PRODUCTION; DOWN REGULATION; DRUG RESEARCH; DRUG TARGETING; ENDOMETRIOSIS; ENZYME INHIBITION; FEMALE INFERTILITY; GENE EXPRESSION; HUMAN; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MEDICAL RESEARCH; MENSTRUAL CYCLE; MENSTRUATION; MESOTHELIUM CELL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERITONEAL FLUID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTION AND FORECASTING; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REVIEW; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BIOLOGICAL MARKERS; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMANS; PROTEOME; PROTEOMICS;

EID: 54349094524     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.5.5.705     Document Type: Review

References (47)

1. Guo SW, Wang Y. Sources of heterogeneities in estimating the prevalence of endometriosis in infertile and previously fertile women. Fertil. Steril. 86(6), 1584-1595 (2006).
2. Guo SW, Wang Y. The prevalence of endometriosis in women with chronic pelvic pain. Gynecol. Obstet. Invest. 62(3), 121-130 (2006).
3. Sampson JA. Peritoneal endometriosis due to menstrual dissemination of endometrial tissue into the peritoneal cavity. Am. J. Obst. Gynecol. 14, 442-469 (1927).
4. Koninckx PR, Kennedy SH, Barlow DH. Endometriotic disease: the role of peritoneal fluid. Hum. Reprod. Update 4(5), 741-751 (1998).
5. Gazvani R, Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis. Reproduction 123(2), 217-226 (2002).
6. Ulukus M, Cakmak H, Arici A. The role of endometrium in endometriosis. J. Soc. Gynecol. Investig. 13(7), 467-476 (2006).
7. Kennedy S, Bergqvist A, Chapron C et al. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum. Reprod. 20(10), 2698-2704 (2005).
8. Ferrero S, Remorgida V. Images in clinical medicine. Endometriosis. N. Engl. J. Med. (7), E8 (2007).
9. Bedaiwy MA, Falcone T. Laboratory testing for endometriosis. Clin. Chim. Acta 340(1-2), 41-56 (2004).
10. Mol BW, Bayram N, Lijmer JG et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil. Steril. 70(6), 1101-1108 (1998).
11. Brosens I, Puttemans P, Campo R, Gordts S, Kinkel K. Diagnosis of endometriosis: pelvic endoscopy and imaging techniques. Best Pract. Res. Clin. Obstet. Gynaecol. 18(2), 285-303 (2004).
12. Bazot M, Thomassin I, Hourani R, Cortez A, Darai E. Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis. Ultrasound Obstet. Gynecol. 24(2), 180-185 (2004).
13. Bazot M, Darai E, Hourani R et al. Deep pelvic endometriosis: MR imaging for diagnosis and prediction of extension of disease. Radiology 232(2), 379-389 (2004).
14. Biscaldi E, Ferrero S, Fulcheri E, Ragni N, Remorgida V, Rollandi GA. Multislice CT enteroclysis in the diagnosis of bowel endometriosis. Eur. Radiol. 17(1), 211-219 (2007).
15. Overton C, Davis C, Mc Millan L, Shaw RW. Basic science of endometriosis. In: An Atlas of Endometriosis (Third Edition). Overton C, Davis C, McMillan L, Shaw RW (Eds). Informa Healthcare, London, UK (2007).
16. Van Langendonckt A, Donnez J, Defrère S, Dunselman GA, Groothuis PG. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises. Mol. Hum. Reprod. 14(5), 259-268 (2008).
17. Varma R, Rollason T, Gupta JK, Maher ER. Endometriosis and the neoplastic process. Reproduction 127(3), 293-304 (2004).
18. Kao LC, Germeyer A, Tulac S et al. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 144(7), 2870-2881 (2003).
19. Sharpe KL, Bertero MC, Vernon MW. Detection of a progesterone-induced secretory protein synthesized by the uteri but not the endometriotic implants of rats with induced endometriosis. Fertil. Steril. 55(2), 403-410 (1991).
20. Sharpe KL, Vernon MW. Polypeptides synthesized and released by rat ectopic uterine implants differ from those of the uterus in culture. Biol. Reprod. 48(6), 1334-1340 (1993).
21. Sharpe KL, Zimmer RL, Griffin WT, Penney LL. Polypeptides synthesized and released by human endometriosis differ from those of the uterine endometrium in cell and tissue explant culture. Fertil. Steril. 60(5), 839-851 (1993).
22. Sharpe-Timms KL, Piva M, Ricke EA, Surewicz K, Zhang YL, Zimmer RL. Endometriotic lesions synthesize and secrete a haptoglobin-like protein. Biol. Reprod. 58(4), 988-994 (1998).
23. Sharpe-Timms KL, Penney LL, Zimmer RL, Wright JA, Zhang Y, Surewicz K. Partial purification and amino acid sequence analysis of endometriosis protein-II (ENDO-II) reveals homology with tissue inhibitor of metalloproteinases-1 (TIMP-1). J. Clin. Endocrinol. Metab. 80(12), 3784-3787 (1995).
24. Zhang H, Niu Y, Feng J, Guo H, Ye X, Cui H. Use of proteomic analysis of endometriosis to identify different protein expression in patients with endometriosis versus normal controls. Fertil. Steril. 86(2), 274-282 (2006).
25. Fowler PA, Tattum J, Bhattacharya S et al. An investigation of the effects of endometriosis on the proteome of human eutopic endometrium: a heterogeneous tissue with a complex disease. Proteomics 7(1), 130-142 (2007). • Study based on 2D polyacrylamide gel electrophoresis and MALDI-TOF demonstrating the aberrant expression of several proteins in the endometrium of women with endometriosis.
26. ten Have S, Fraser I, Markham R, Lam A, Matsumoto I. Proteomic analysis of protein expression in the eutopic endometrium of women with endometriosis. Proteomics Clin. Appl. 1(10), 1243-1251 (2007).
27. Kyama CM, T'Jampens D, Mihalyi A et al. ProteinChip technology is a useful method in the pathogenesis and diagnosis of endometriosis: a preliminary study. Fertil. Steril. 86(1), 203-209 (2006).
28. Demir Weusten AY, Groothuis PG, Dunselman GA, de Goeij AF, Arends JW, Evers JL. Morphological changes in mesothelial cells induced by shed menstrual endometrium in vitro are not primarily due to apoptosis or necrosis. Hum. Reprod. 15(7), 1462-1468 (2000).
29. Demir AY, Demol H, Puype M et al. Proteome analysis of human mesothelial cells during epithelial to mesenchymal transitions induced by shed menstrual effluent. Proteomics 4(9), 2608-2623 (2004).
30. Hou Z, Zhou J, Ma X, Fan L, Liao L, Liu J. Role of interleukin-1 receptor type II in the pathogenesis of endometriosis. Fertil. Steril. 89(1), 42-51 (2008).
31. Nothnick WB, Curry TE Jr, Muse KN, London SN, Vernon MW. Detection of a unique 32-kd protein in the peritoneal fluid of women with endometriosis. Fertil. Steril. 61(2), 288-293 (1994).
32. Tabibzadeh S, Becker JL, Parsons AK. Endometriosis is associated with alterations in the relative abundance of proteins and IL-10 in the peritoneal fluid. Front. Biosci. 8, A70-A78 (2003).
33. Ferrero S, Gillott DJ, Anserini P et al. Vitamin D binding protein in endometriosis. J. Soc. Gynecol. Investig. 12(4), 272-277 (2005).
34. Ferrero S, Gillott DJ, Remorgida V et al. Proteomic analysis of peritoneal fluid in women with endometriosis. J. Proteome Res. 6(9), 3402-3411 (2007). • Study based on 2D polyacrylamide gel electrophoresis and liquid chromatography tandem mass spectrometry, demonstrating the aberrant expression of several proteins in peritoneal fluid of women with endometriosis.
35. Ferrero S, Gillott DJ, Remorgida V et al. Haptoglobin β chain isoforms in the plasma and peritoneal fluid of women with endometriosis. Fertil. Steril. 83(5), 1536-1543 (2005). • Demonstrates the aberrant expression of one haptoglobin β-chain isoform in plasma and peritoneal fluid of women with endometriosis.
36. Ferrero S, Gillott DJ, Remorgida V, Anserini P, Ragni N, Grudzinskas JG. Proteomic research of new plasmatic markers of endometriosis. Fertil. Steril. 82 (Suppl. 2), S163-S164 (2004).
37. Wang L, Zheng W, Yu JK, Jiang WZ, Mu L, Zhang SZ. Artificial neural networks combined with surface-enhanced laser desorption/ionization mass spectra distinguish endometriosis from healthy population. Fertil. Steril. 88(6), 1700-1702 (2007).
38. Wang L, Zheng W, Mu L, Zhang SZ. Identifying biomarkers of endometriosis using serum protein fingerprinting and artificial neural networks. Int. J. Gynaecol. Obstet. 101(3), 253-258 (2008). •• Demonstrates that SELDI mass spectra may allow the distinction between women with and without endometriosis.
39. Liu H, Lang J, Zhou Q, Shan D, Li Q. Detection of endometriosis with the use of plasma protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Fertil. Steril. 87(4), 988-990 (2007).
40. Seeber BE, Fan X, Sammel MD, Gerton GL, Shaunik A, Barnhart KT. Serum markers of endometriosis: a proteomics approach to diagnosis. Fertil. Steril. 86(3 Suppl.), S273 (2006).
41. Witz CA. Cell adhesion molecules and endometriosis. Semin. Reprod. Med. 21(2), 173-182 (2003).
42. Brack SS, Dinkelborg LM, Neri D. Molecular targeting of angiogenesis for imaging and therapy. Eur. J. Nucl. Med. Mol. Imaging 31(9), 1327-1341 (2004).
43. Espina V, Dettloff KA, Cowherd S, Petricoin EF 3rd, Liotta LA. Use of proteomic analysis to monitor responses to biological therapies. Expert Opin. Biol. Ther. 4(1), 83-93 (2004).
44. Davidson B, Espina V, Steinberg SM et al. Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clin. Cancer Res. 12, 791-799 (2006).
45. Yanagisawa K, Shyr Y, Xu BJ et al. Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 362(9382), 433-439 (2003).
46. Borkowski J, Gmyrek GB, Madej JP et al. Serum and peritoneal evaluation of vitamin D-binding protein in women with endometriosis. Postepy Hig. Med. Dosw. (Online) 62, 103-109 (2008).
47. Ferrero S, Abbamonte LH, Anserini P, Remorgida V, Ragni N. Future perspectives in the medical treatment of endometriosis. Obstet. Gynecol. Surv. 60(12), 817-826 (2005).